06.04.2013 Views

MVCA 2011 Annual Report - Grand Angels

MVCA 2011 Annual Report - Grand Angels

MVCA 2011 Annual Report - Grand Angels

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ANNUAL INVESTMENT IN MIChIgAN<br />

Venture capital investment in Michigan during <strong>2011</strong> represents the third highest annual<br />

investment in the past ten years with a new annual record of 38 investments.<br />

$300M<br />

$250M<br />

$200M<br />

$150M<br />

$100M<br />

$50M<br />

$0M<br />

2001<br />

MiChigAN VENTurE CAPiTAL iNVESTMENTS<br />

(2001-<strong>2011</strong>)<br />

2002 2003 2004 2005 2006 2007 2008 2009 2010 <strong>2011</strong><br />

Amount invested in Michigan # of investments<br />

n Since 2001, $1.5 billion of venture capital has been<br />

invested into 250 companies.<br />

COMPANY<br />

SPOTLIGHT<br />

INTERVENTION INSIGHTS<br />

A West Michigan company born out of research<br />

performed at <strong>Grand</strong> Rapids’ Van Andel Research<br />

Institute is at the leading edge of cancer-fighting<br />

technology, offering patients and their doctors a<br />

genetic map to best evaluate treatment options.<br />

Intervention Insights, a <strong>Grand</strong> Rapids-based<br />

pharmacogenomics service provider, takes<br />

personalized medicine one step further by supplying<br />

oncologists with molecular-based analysis to better<br />

match drug therapies to a unique cancer type.<br />

The company markets its decision support tool as an<br />

information service for community-based oncologists<br />

who treat more than 80% of all U.S. cancer patients.<br />

n The average annual investment over the decade is<br />

$138 million. Over the last 5 years, since 2007, the<br />

average annual investment is $176 million.<br />

Recently the company won an “Innovation<br />

Michigan” award from Business Review of West<br />

Michigan and was one of seven finalists out of more<br />

than than 1,700 entries in Amazon Web Services’<br />

annual innovation search. The company has<br />

successfully launched two payer-sponsored clinical<br />

studies and has opened an Investigational Device<br />

Exemption with the FDA in support of its services.<br />

In <strong>2011</strong>, Intervention Insights closed a $7.2<br />

million Series B funding round, including Michigan<br />

venture investors Beringea, Chrysalis Ventures,<br />

Hopen Life Sciences, the Charter Group and the<br />

Michigan Accelerator Fund. n<br />

40<br />

35<br />

30<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

MICHIGAN<br />

<strong>MVCA</strong> <strong>2011</strong> VENTURE CAPITAL REPORT<br />

29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!